Correlation Between Leap Therapeutics and Adaptimmune Therapeutics
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Adaptimmune Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Adaptimmune Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Adaptimmune Therapeutics Plc, you can compare the effects of market volatilities on Leap Therapeutics and Adaptimmune Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Adaptimmune Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Adaptimmune Therapeutics.
Diversification Opportunities for Leap Therapeutics and Adaptimmune Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Leap and Adaptimmune is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Adaptimmune Therapeutics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptimmune Therapeutics and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Adaptimmune Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptimmune Therapeutics has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Adaptimmune Therapeutics go up and down completely randomly.
Pair Corralation between Leap Therapeutics and Adaptimmune Therapeutics
Given the investment horizon of 90 days Leap Therapeutics is expected to generate 1.01 times more return on investment than Adaptimmune Therapeutics. However, Leap Therapeutics is 1.01 times more volatile than Adaptimmune Therapeutics Plc. It trades about -0.08 of its potential returns per unit of risk. Adaptimmune Therapeutics Plc is currently generating about -0.1 per unit of risk. If you would invest 306.00 in Leap Therapeutics on August 24, 2024 and sell it today you would lose (48.00) from holding Leap Therapeutics or give up 15.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Leap Therapeutics vs. Adaptimmune Therapeutics Plc
Performance |
| Timeline |
| Leap Therapeutics |
| Adaptimmune Therapeutics |
Leap Therapeutics and Adaptimmune Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Leap Therapeutics and Adaptimmune Therapeutics
The main advantage of trading using opposite Leap Therapeutics and Adaptimmune Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Adaptimmune Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will offset losses from the drop in Adaptimmune Therapeutics' long position.| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |